You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

treatment of atherosclerotic disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease, Atherosclerosis, Coronary Atherosclerosis of Native Coronary Artery Trial in Baltimore (PET/CT)

Recruiting
  • Coronary Artery Disease
  • +2 more
  • PET/CT
  • Baltimore, Maryland
    Johns Hopkins Hospital
Aug 8, 2023

ICAD - Intracranial Atherosclerotic Disease Trial (Colchicine 0.5 MG)

Not yet recruiting
  • ICAD - Intracranial Atherosclerotic Disease
  • Colchicine 0.5 MG
  • (no location specified)
Aug 14, 2022

Peripheral Arterial Disease, Common Femoral Artery Stenosis, Common Femoral Artery Occlusion Trial (Intravascular litothripsy

Not yet recruiting
  • Peripheral Arterial Disease
  • +3 more
  • Intravascular litothripsy (IVL)
  • (no location specified)
Apr 7, 2023

Intracranial Arterial Diseases, Stent Restenosis, Percutaneous Transluminal Angioplasty Trial in Shanghai (Self-expanding

Recruiting
  • Intracranial Arterial Diseases
  • +2 more
  • Self-expanding intracranial drug stent system
  • Shanghai, China
    Changhai Hospital
Jan 18, 2023

Cardiovascular Diseases, Smoking, Tobacco Use Trial (Cigarette, THS, Smoking Abstinence)

Not yet recruiting
  • Cardiovascular Diseases
  • +4 more
  • Cigarette
  • +2 more
  • (no location specified)
Jan 17, 2023

Atherosclerotic Plaque Development in Human

Not yet recruiting
  • Coronary Heart Disease, Susceptibility to, 1
  • No intervention
  • (no location specified)
Jul 13, 2023

Qualitative Features of Atherosclerotic Plaques

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • Riga, Latvia
    Pauls Stradins Clinical University Hospital
Dec 5, 2022

Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic

Recruiting
  • Atherosclerosis
  • Aortic Valve Disease
  • Thrombotic assessment
  • Measurement of Lp(a)
  • Stevenage, United Kingdom
    East and North Herts NHS Trust
Nov 6, 2023

Hypercholesterolemia, Atherosclerotic Disease, Coronary Disease Trial (MK0653A , ezetimibe (+) simvastatin, Comparator:

Completed
  • Hypercholesterolemia
  • +2 more
  • MK0653A , ezetimibe (+) simvastatin
  • +2 more
  • (no location specified)
Feb 3, 2022

Intracranial Atherosclerosis Trial in Chicago (Feraheme)

Recruiting
  • Intracranial Atherosclerosis
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

sessmenT and treAtment In AustraliaN Primary Care

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • +3 more
  • Inclisiran Prefilled Syringe
  • Clayton, Victoria, Australia
    Monash Health
Apr 17, 2023

Apical Periodontitis and Atherosclerotic Cardiovascular Diseases

Recruiting
  • Apical Periodontitis
  • Atherosclerotic Cardiovascular Disease
  • Echo-color-doppler
  • Siena, Italy
    Azienda Ospedaliera Universitaria Senese
Mar 19, 2023

Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)

Recruiting
  • Atherosclerosis of Artery
  • +3 more
  • Rivaroxaban 2.5mg
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 2, 2023

ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

Not yet recruiting
  • ASCVD
  • Coronary Artery Calcification
  • Notification of patients and clinicians
  • (no location specified)
May 5, 2023

Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)

Not yet recruiting
  • Dyslipidemias
  • Atherosclerotic Cardiovascular Disease
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jan 29, 2023

Understand Real-world Awareness and Perceptions for Systemic

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • Chronic Kidney Disease (CKD)
  • No treatment given
  • Bangalore, India
    Novo Nordisk Investigational Site
Feb 23, 2023

Intracranial Atherosclerotic Disease, Stroke, Angioplasty, Balloon Trial in Chicago (Submaximal balloon angioplasty, Intensive

Not yet recruiting
  • Intracranial Atherosclerotic Disease
  • +4 more
  • Submaximal balloon angioplasty
  • Intensive medical therapy
  • Chicago, Illinois
    University oif Illinois at Chicago
Nov 10, 2021

Identifying Vulnerable CoronAry PLaqUes With Artificial

Enrolling by invitation
  • Coronary Artery Disease
  • Plaque, Atherosclerotic
  • Intravascular imaging test
  • Nanjing, Jiangsu, China
    Research Institute Of Medical Imaging Jinling Hospital
Sep 5, 2023

Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
  • Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
  • (no location specified)
Mar 14, 2023

Prediction of Atherosclerotic Plaque Progression

Active, not recruiting
  • Coronary Artery Disease
  • OCT, NIRS
  • Prague, Czechia
    Na Homolce Hospital
Jun 15, 2022

Inclisiran on Major Adverse Cardiovascular Events in French

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium
  • +3 more
  • (no location specified)
Jul 26, 2023

Cardiovascular Diseases Trial in Umeå (Intervention)

Active, not recruiting
Has Results
  • Cardiovascular Diseases
  • Intervention
  • Umeå, Sweden
    Clinical Reseach Center Umeå University Hospital
Aug 18, 2021

Coronary Artery Disease Trial in Jining (SeQuent® Please drug coating balloon(DCB),Firehawk family drug eluting stent(DES))

Recruiting
  • Coronary Artery Disease
  • SeQuent® Please drug coating balloon(DCB)，Firehawk family drug eluting stent(DES)
  • Jining, Shandong, China
    Jining Medical University Affiliated Hospital
Jul 23, 2023

The Belgian REAL (BE.REAL) Registry

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran
  • (no location specified)
Feb 3, 2023

Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a) Trial (SLN360, Placebo)

Not yet recruiting
  • Cardiovascular Diseases
  • +2 more
  • (no location specified)
Sep 12, 2022